GLP-1 medication set Jamie on the right track with her body and fitness goals, however she was still dealing with excess weight around her midsection..
Unlike GLP-1's, our TriSculpt technique helps spot reduce and sculpt your problem areas. Jamie was able to perfect her body goals and achieve the figure she's worked so hard to obtain!
Sono Bello and GLP-1's can be an amazing pair to reach your body goals
📝Procedure: AbEX
📍 Sono Bello Center: San Antonio, TX
🧐 Areas: Full Abdomen, Waist
👩⚕️ Surgeon: Dr. Schaner
➡️ Book a Free Consult: https://bit.ly/SBFreeConsultation
#sonobelloambassador
The story of a 25-year-old nurse who came off of Ozempic after 11 months. It's not rocket science-- you've got to continue to eat healthy, move, and manage sleep and stress to keep weight off.
#ozempic #ozempicrebound #ozempicweightloss #wegovy #wegovyrebound #mounjaro #semaglutide #semaglutideforweightloss #weightgainjourney #flexbymove78 #youtubeshorts
#ozempic #beforeandafter #diabetesmedication #weightloss #glp1forweightloss #healthy #healthynutrition #gym #progress #shorts #injection #glp1medication #ozempicjourney #ozempicweightloss
Oats Smoothie -2 || #weightloss #healthylifestyle #healthyfood #oats #breakfast #cooking #minivlog
Currax Pharmaceuticals CEO George Hampton talks about the demand for the FDA-approved obesity drug Contrave. Demand is growing fast. He is on "Bloomberg Open Interest."
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9
Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.
Connect with Bloomberg Television on:
X: https://twitter.com/BloombergTV
Facebook: https://www.facebook.com/BloombergTelevision
Instagram: https://www.instagram.com/bloombergtv/
Connect with Bloomberg Business on:
X: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
TikTok: https://www.tiktok.com/@bloombergbusiness?lang=en
Reddit: https://www.reddit.com/r/bloomberg/
LinkedIn: https://www.linkedin.com/company/bloomberg-news/
More from Bloomberg:
Bloomberg Radio: https://twitter.com/BloombergRadio
Bloomberg Surveillance: https://twitter.com/bsurveillance
Bloomberg Politics: https://twitter.com/bpolitics
Bloomberg Originals: https://twitter.com/bbgoriginals
Watch more on YouTube:
Bloomberg Technology: https://www.youtube.com/@BloombergTechnology
Bloomberg Originals: https://www.youtube.com/@business
Bloomberg Quicktake: https://www.youtube.com/@BloombergQuicktake
Bloomberg Espanol: https://www.youtube.com/@bloomberg_espanol
Bloomberg Podcasts: https://www.youtube.com/@BloombergPodcasts
Witness Jelly Roll's amazing 200lb weight loss journey! From his show-stopping appearance at the ACM Awards with wife Bunnie Xo, to his inspiring interviews and mountain hikes, see how he's transformed his life. Hear his emotional story, his motivation, and his ambitious goal to be on the cover of Men's Health! This video celebrates Jelly Roll's dedication, his honesty about his struggles, and his powerful message of hope and determination.
Highlights:
* Jelly Roll's stunning ACM Awards appearance and his 200lb weight loss reveal.
* His emotional interview with Entertainment Tonight about his transformation.
* Bunnie Xo's glamorous red carpet look.
* Details about Jelly Roll's new healthy lifestyle, including hiking and prioritizing his well-being.
* His inspiring goal to be on the cover of Men's Health in March 2026.
* How he's inspiring others with his journey of recovery and courage.
* Clips from Bunnie Xo's podcast where Jelly Roll discusses his weight loss journey.
#jellyroll #weightloss #transformation #acmawards #bunniexo #inspiration #health #menshealth #countrymusic #celebrityweightloss #motivation #fitnessaddict
You might be losing some Muscle instead of Fat
#MusclePreservation #ProteinIntake #FitnessTips
Obesity is a prevalent health issue affecting millions of people worldwide. The World Health Organization (WHO) has declared it a global epidemic, with significant implications for individuals’ health and well-being. For many individuals struggling with obesity, lifestyle modifications such as diet and exercise may not always be enough to achieve substantial and sustainable weight loss. In such cases, medication can play a crucial role in aiding weight management.
Dulaglutide vs Semaglutide: Understanding the Options
Two medications that have gained attention in recent years for their potential in aiding weight loss are Dulaglutide and Semaglutide. Both medications belong to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and are approved for the management of type 2 diabetes. However, their use in weight management in individuals without diabetes has sparked interest and research into their efficacy and safety for this purpose.
Dulaglutide, sold under the brand name Trulicity, is a once-weekly injectable medication that works by mimicking the action of a hormone called GLP-1. It helps regulate blood sugar levels, promotes feelings of fullness, and slows down gastric emptying, all of which can contribute to weight loss. On the other hand, Semaglutide, marketed under the brand name Ozempic, is also a once-weekly injectable GLP-1 RA that has shown promising results in weight management in clinical trials.
Comparative Analysis of Dulaglutide and Semaglutide
When comparing Dulaglutide and Semaglutide for weight loss, several factors need to be considered, including their efficacy, safety, tolerability, and cost. Both medications have been evaluated in clinical trials specifically designed to assess their impact on weight reduction in individuals with obesity or overweight. These studies have provided valuable insights into the relative strengths and limitations of each medication.
One key consideration in comparing Dulaglutide and Semaglutide is their effectiveness in promoting weight loss. Clinical trials have shown that both medications can lead to significant reductions in body weight when used as part of a comprehensive weight management program that includes diet and exercise. However, Semaglutide has been shown to be more potent in inducing weight loss compared to Dulaglutide, with some trials reporting greater weight reduction with Semaglutide treatment.
In terms of safety and tolerability, both Dulaglutide and Semaglutide have been generally well-tolerated in clinical trials, with nausea being the most commonly reported side effect. However, Semaglutide has been associated with a slightly higher incidence of gastrointestinal side effects compared to Dulaglutide. Additionally, Semaglutide has also been linked to a slightly higher risk of pancreatitis and gallbladder-related adverse events, although the overall risk is considered low.
Conclusion
In conclusion, both Dulaglutide and Semaglutide offer promising options for individuals seeking to manage their weight effectively. While Dulaglutide may be a suitable choice for some individuals, especially those who prioritize convenience and ease of use due to its once-weekly dosing, Semaglutide stands out as a more potent option for inducing weight loss. Ultimately, the choice between Dulaglutide and Semaglutide should be guided by individual preferences, goals, and considerations, as well as consultation with a healthcare provider.
Overall, the comparative analysis of Dulaglutide and Semaglutide highlights the importance of personalized medicine in weight management and underscores the need for further research to better understand the optimal use of these medications in the context of obesity treatment. With ongoing advancements in pharmacotherapy and a growing emphasis on individualized care, individuals struggling with obesity now have more options available to support their weight loss journeys.
